To start this activity click Next at the bottom of this page
Release date: February 1, 2015
Expiration date: February 29, 2016
STATEMENT OF NEED/PROGRAM OVERVIEW
Patients undergoing hematopoietic stem cell transplantation (HSCT) are more susceptible to invasive fungal infections because their therapy includes immunosuppression. Aspergillosis is the most common fungal infection and the most common cause of infectious death among HSCT recipients. Successful treatment depends on early diagnosis; however, diagnosis can be difficult. This activity discusses the host and environment risk factors that contribute to invasive aspergillosis (IA), as well as diagnostic tests and treatment options for managing the treatment of these patients.
Connie C. Chettle, MS, MPH, RN
St. George, Utah
To better understand how cancer immunotherapies use the body’s natural defenses to identify and kill cancer cells.
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 1 contact hour of continuing nursing education, of which 0.20 is pharmacology.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hour.
METHOD OF PARTICIPATION
There are no fees for participating in and receiving credit for this activity. During the period February 2015 through February 2016, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by selecting the best answer to each question on the posttest, 4) complete the evaluation form, and 5) continue tonext section to claim credits and view your certificate.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Statements of credit are available at the conclusion of the activity.
Journal article and Web site (myCME.com; OncologyNurseAdvisor.com)
Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Name of faculty: Connie C. Chettle, MS, MPH, RN
Reported Financial Relationship: No financial relationships to disclose
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Name of Content Manager and Reported Financial Relationship
Joyce Pagán (No financial relationships to disclose)
Planners and Manager from MER (No financial relationships to disclose)
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources or Haymarket Medical. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources or Haymarket Medical. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
HOW TO TAKE THE POST-TEST: To obtain CE credit, please click here after reading the article to take the post-test on myCME.com.